360 related articles for article (PubMed ID: 17891190)
1. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.
Jares P; Colomer D; Campo E
Nat Rev Cancer; 2007 Oct; 7(10):750-62. PubMed ID: 17891190
[TBL] [Abstract][Full Text] [Related]
2. Advances in the understanding of mantle cell lymphoma.
Jares P; Campo E
Br J Haematol; 2008 Jun; 142(2):149-65. PubMed ID: 18410453
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of mantle cell lymphoma: from profiling studies to new therapeutic strategies.
Obrador-Hevia A; Fernández de Mattos S; Villalonga P; Rodríguez J
Blood Rev; 2009 Sep; 23(5):205-16. PubMed ID: 19362399
[TBL] [Abstract][Full Text] [Related]
4. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
[TBL] [Abstract][Full Text] [Related]
5. Flipping the cyclin D1 switch in mantle cell lymphoma.
Hasanali Z; Sharma K; Epner E
Best Pract Res Clin Haematol; 2012 Jun; 25(2):143-52. PubMed ID: 22687450
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of mantle cell lymphoma: new perspectives and challenges with clinical implications.
Navarro A; Royo C; Hernández L; Jares P; Campo E
Semin Hematol; 2011 Jul; 48(3):155-65. PubMed ID: 21782057
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the mammalian target of rapamycin and the induction of cell cycle arrest in mantle cell lymphoma cells.
Hipp S; Ringshausen I; Oelsner M; Bogner C; Peschel C; Decker T
Haematologica; 2005 Oct; 90(10):1433-4. PubMed ID: 16219581
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: advances in biology and therapy.
Smith MR
Curr Opin Hematol; 2008 Jul; 15(4):415-21. PubMed ID: 18536582
[TBL] [Abstract][Full Text] [Related]
9. Mantle cell lymphoma in relapse: the role of emerging new drugs.
Diefenbach CS; O'Connor OA
Curr Opin Oncol; 2010 Sep; 22(5):419-23. PubMed ID: 20679769
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of novel cell cycle inhibitors in mantle cell lymphoma.
Park IW; Reddy MV; Reddy EP; Groopman JE
Oncogene; 2007 Aug; 26(38):5635-42. PubMed ID: 17369860
[TBL] [Abstract][Full Text] [Related]
11. Treatment of mantle cell lymphoma: targeting the microenvironment.
Drach J; Seidl S; Kaufmann H
Expert Rev Anticancer Ther; 2005 Jun; 5(3):477-85. PubMed ID: 16001955
[TBL] [Abstract][Full Text] [Related]
12. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes.
Ferrer A; Marcé S; Bellosillo B; Villamor N; Bosch F; López-Guillermo A; Espinet B; Solé F; Montserrat E; Campo E; Colomer D
Oncogene; 2004 Nov; 23(55):8941-9. PubMed ID: 15480431
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma: biological insights and treatment advances.
Leonard JP; Williams ME; Goy A; Grant S; Pfreundschuh M; Rosen ST; Sweetenham JW
Clin Lymphoma Myeloma; 2009 Aug; 9(4):267-77. PubMed ID: 19717376
[TBL] [Abstract][Full Text] [Related]
14. Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma.
Yazbeck VY; Buglio D; Georgakis GV; Li Y; Iwado E; Romaguera JE; Kondo S; Younes A
Exp Hematol; 2008 Apr; 36(4):443-50. PubMed ID: 18343280
[TBL] [Abstract][Full Text] [Related]
15. Combined administration of rituximab and on 013105 induces apoptosis in mantle cell lymphoma cells and reduces tumor burden in a mouse model of mantle cell lymphoma.
Prasad A; Shrivastava A; Papadopoulos E; Kuzontkoski PM; Reddy MV; Gillum AM; Kumar R; Reddy EP; Groopman JE
Clin Cancer Res; 2013 Jan; 19(1):85-95. PubMed ID: 23124440
[TBL] [Abstract][Full Text] [Related]
16. Update on the molecular biology of mantle cell lymphoma.
Bertoni F; Rinaldi A; Zucca E; Cavalli F
Hematol Oncol; 2006 Mar; 24(1):22-7. PubMed ID: 16402392
[TBL] [Abstract][Full Text] [Related]
17. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
[TBL] [Abstract][Full Text] [Related]
18. The molecular signature of mantle cell lymphoma reveals multiple signals favoring cell survival.
Martínez N; Camacho FI; Algara P; Rodríguez A; Dopazo A; Ruíz-Ballesteros E; Martín P; Martínez-Climent JA; García-Conde J; Menárguez J; Solano F; Mollejo M; Piris MA
Cancer Res; 2003 Dec; 63(23):8226-32. PubMed ID: 14678979
[TBL] [Abstract][Full Text] [Related]
19. Genomic profiling of mantle cell lymphoma.
Menanteau MR; Martinez-Climent JA
Methods Mol Biol; 2013; 973():147-63. PubMed ID: 23412788
[TBL] [Abstract][Full Text] [Related]
20. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]